Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Morel

Showing results (61-70 of 197) with videos related to

Pageof 20
Sort By:
Arthritis Care & Research|December 21, 2018
Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta-AnalysisAurélie Beltai, Thomas Barnetche, Claire Daien, et al.
The Journal of Rheumatology|July 15, 2003
Polymorphism of HLA-DMA and DMB alleles in patients with systemic lupus erythematosusJacques Morel, Clarisse Da Silva Simoes, Odile Avinens, et al.
Arthritis and Rheumatism|February 10, 2011
Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritisRachel Audo, Flavia Calmon-Hamaty, Dominique Baeten, et al.
Arthritis Care & Research|March 28, 2020
Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-AnalysisGuillaume Decarriere, Thomas Barnetche, Bernard Combe, et al.
Annals of the Rheumatic Diseases|October 4, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysisClaire Rempenault, Bernard Combe, Thomas Barnetche, et al.
RMD Open|January 31, 2024
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory diseaseClaire Rempenault, Cédric Lukas, Léa Tardivon, et al.
Rheumatology (Oxford, England)|July 1, 2026
Stability and prognostic value of B-cell markers in primary Sjögren's syndrome: results from the French ASSESS cohortPaulina Szafors, Cedric Lukas, Bernard Combe, et al.
The Journal of Rheumatology|May 18, 2010
Tumor necrosis factor-alpha blockers in SAPHO syndromeKaouther Ben Abdelghani, Delphine Gerard Dran, Jacques-Eric Gottenberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2014
Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activityClaire I Daien, Sarah Gailhac, Thibault Mura, et al.
Rheumatology (Oxford, England)|September 19, 2014
High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritisClaire Immediato Daïen, Sarah Gailhac, Rachel Audo, et al.
Pageof 20

Showing results (61-70 of 197) with videos related to

Sort By:
Pageof 20
Arthritis Care & Research|December 21, 2018
Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta-AnalysisAurélie Beltai, Thomas Barnetche, Claire Daien, et al.
The Journal of Rheumatology|July 15, 2003
Polymorphism of HLA-DMA and DMB alleles in patients with systemic lupus erythematosusJacques Morel, Clarisse Da Silva Simoes, Odile Avinens, et al.
Arthritis and Rheumatism|February 10, 2011
Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritisRachel Audo, Flavia Calmon-Hamaty, Dominique Baeten, et al.
Arthritis Care & Research|March 28, 2020
Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-AnalysisGuillaume Decarriere, Thomas Barnetche, Bernard Combe, et al.
Annals of the Rheumatic Diseases|October 4, 2017
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysisClaire Rempenault, Bernard Combe, Thomas Barnetche, et al.
RMD Open|January 31, 2024
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory diseaseClaire Rempenault, Cédric Lukas, Léa Tardivon, et al.
Rheumatology (Oxford, England)|July 1, 2026
Stability and prognostic value of B-cell markers in primary Sjögren's syndrome: results from the French ASSESS cohortPaulina Szafors, Cedric Lukas, Bernard Combe, et al.
The Journal of Rheumatology|May 18, 2010
Tumor necrosis factor-alpha blockers in SAPHO syndromeKaouther Ben Abdelghani, Delphine Gerard Dran, Jacques-Eric Gottenberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2014
Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activityClaire I Daien, Sarah Gailhac, Thibault Mura, et al.
Rheumatology (Oxford, England)|September 19, 2014
High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritisClaire Immediato Daïen, Sarah Gailhac, Rachel Audo, et al.
Pageof 20